# New Treatment for COVID-19 Using Ethanol Vapor Inhalation .

> **NCT04554433** · PHASE3 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 80 (estimated)

## Conditions studied

- Covid-19
- Drug Effect

## Interventions

- **DRUG:** Ethanol with Asprin

## Key facts

- **NCT ID:** NCT04554433
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2021-10-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04554433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04554433, "New Treatment for COVID-19 Using Ethanol Vapor Inhalation .". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04554433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*